|
OMIM |
Link |
Information gain |
01 |
|
VMD1
|
[NCBI]
|
0.00264194
|
|
|
ATD1
|
[NCBI]
|
0.00192174
|
|
|
GPT
|
[NCBI]
|
0.00168061
|
|
|
WDM
|
[NCBI]
|
0.00156007
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
0.000584974
|
|
|
CAT
|
[NCBI]
|
0.000395427
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.000285263
|
|
|
epidermolysis bullosa simplex, ogna type
|
[NCBI]
|
0.000249114
|
|
|
MPO
|
[NCBI]
|
0.000246664
|
|
|
TNF
|
[NCBI]
|
0.000220416
|
|
|
AGXT
|
[NCBI]
|
0.000176932
|
|
|
ALB
|
[NCBI]
|
0.000164921
|
|
|
cerebellar vermis aplasia with associated features suggesting smith-lemli-opitz syndrome and meckel syndrome
|
[NCBI]
|
0.000155954
|
|
|
melanoma, uveal
|
[NCBI]
|
0.000153979
|
|
|
PFIC1
|
[NCBI]
|
0.000152141
|
|
|
glycogen storage disease iii
|
[NCBI]
|
0.000150377
|
|
|
HGF
|
[NCBI]
|
0.000140973
|
|
|
glycine n-methyltransferase deficiency
|
[NCBI]
|
0.000124387
|
|
|
carnitine acetyltransferase deficiency
|
[NCBI]
|
0.000124387
|
|
|
cirrhosis, familial
|
[NCBI]
|
0.000112488
|
|
|
bile acid synthesis defect, congenital, 1
|
[NCBI]
|
9.44702e-05
|
|
|
mitochondrial myopathy
|
[NCBI]
|
9.06785e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
9.03026e-05
|
|
|
australia antigen
|
[NCBI]
|
8.7436e-05
|
|
|
CMD3B
|
[NCBI]
|
8.7436e-05
|
|
|
creatine phosphokinase, elevated serum
|
[NCBI]
|
8.7436e-05
|
|
|
sea-blue histiocyte disease
|
[NCBI]
|
8.46042e-05
|
|
|
epidermolysis bullosa dystrophica, pasini type
|
[NCBI]
|
8.20911e-05
|
|
|
AFP
|
[NCBI]
|
8.02604e-05
|
|
|
ICP
|
[NCBI]
|
7.77822e-05
|
|
|
IFNA1
|
[NCBI]
|
7.12536e-05
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
6.96723e-05
|
|
|
FBS
|
[NCBI]
|
6.83552e-05
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
6.17807e-05
|
|
|
ESD
|
[NCBI]
|
5.92103e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
5.91149e-05
|
|
|
ALGS1
|
[NCBI]
|
5.82949e-05
|
|
|
DM2
|
[NCBI]
|
5.7505e-05
|
|
|
glycogen storage disease v
|
[NCBI]
|
5.46084e-05
|
|
|
SCA2
|
[NCBI]
|
5.0332e-05
|
|
|
breast cancer
|
[NCBI]
|
4.82303e-05
|
|
|
XDH
|
[NCBI]
|
4.6715e-05
|
|
|
NR1I3
|
[NCBI]
|
4.57104e-05
|
|
|
CSF2
|
[NCBI]
|
4.24752e-05
|
|
|
NPC1
|
[NCBI]
|
4.04304e-05
|
|
|
PTH
|
[NCBI]
|
3.75507e-05
|
|
|
ACHE
|
[NCBI]
|
3.7171e-05
|
|
|
GPT2
|
[NCBI]
|
3.40392e-05
|
|
|
EGF
|
[NCBI]
|
2.95181e-05
|
|
|
PCNA
|
[NCBI]
|
2.67046e-05
|
|
|
EGFR
|
[NCBI]
|
2.64685e-05
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
2.64661e-05
|
|
|
VEGF
|
[NCBI]
|
2.47345e-05
|
|
|
GSTA1
|
[NCBI]
|
2.38323e-05
|
|
|
PRL
|
[NCBI]
|
2.35149e-05
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
2.11684e-05
|
|
|
SLOS
|
[NCBI]
|
1.98466e-05
|
|
|
CCK
|
[NCBI]
|
1.97706e-05
|
|
|
PDXK
|
[NCBI]
|
1.67148e-05
|
|
|
GPX4
|
[NCBI]
|
1.67148e-05
|
|
|
IDH2
|
[NCBI]
|
1.67148e-05
|
|
|
GIST
|
[NCBI]
|
1.62532e-05
|
|
|
NFE2L2
|
[NCBI]
|
1.61877e-05
|
|
|
ALDH3A1
|
[NCBI]
|
1.57095e-05
|
|
|
CPB2
|
[NCBI]
|
1.53851e-05
|
|
|
SLE
|
[NCBI]
|
1.50073e-05
|
|
|
TNFSF6
|
[NCBI]
|
1.47062e-05
|
|
|
HP
|
[NCBI]
|
1.45561e-05
|
|
|
NQO1
|
[NCBI]
|
1.44955e-05
|
|
|
MT1A
|
[NCBI]
|
1.44955e-05
|
|
|
GOT1
|
[NCBI]
|
1.44955e-05
|
|
|
ACY1
|
[NCBI]
|
1.41475e-05
|
|
|
PI
|
[NCBI]
|
1.41201e-05
|
|
|
MTP
|
[NCBI]
|
1.38219e-05
|
|
|
ENO1
|
[NCBI]
|
1.3516e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
1.30119e-05
|
|
|
TLR4
|
[NCBI]
|
1.27698e-05
|
|
|
INS
|
[NCBI]
|
1.19956e-05
|
|
|
LTC4S
|
[NCBI]
|
1.13772e-05
|
|
|
SLC22A5
|
[NCBI]
|
1.10062e-05
|
|
|
PGP
|
[NCBI]
|
1.10062e-05
|
|
|
CP
|
[NCBI]
|
1.07358e-05
|
|
|
CDK4
|
[NCBI]
|
1.06006e-05
|
|
|
GSTP1
|
[NCBI]
|
1.0498e-05
|
|
|
MBP
|
[NCBI]
|
1.04685e-05
|
|
|
EPO
|
[NCBI]
|
1.03411e-05
|
|
|
GPX1
|
[NCBI]
|
1.00387e-05
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
9.62008e-06
|
|
|
ADRP
|
[NCBI]
|
9.48844e-06
|
|
|
GNMT
|
[NCBI]
|
8.88101e-06
|
|
|
wolman disease
|
[NCBI]
|
8.55174e-06
|
|
|
KLK3
|
[NCBI]
|
8.47506e-06
|
|
|
DAO
|
[NCBI]
|
7.35238e-06
|
|
|
C3
|
[NCBI]
|
7.27242e-06
|
|
|
MMP9
|
[NCBI]
|
7.11684e-06
|
|
|
CYP1A1
|
[NCBI]
|
6.6103e-06
|
|
|
ADA
|
[NCBI]
|
6.40132e-06
|
|
|
TGFB1
|
[NCBI]
|
6.28783e-06
|
|
|
TNFSF10
|
[NCBI]
|
6.28253e-06
|
|
|
CRH
|
[NCBI]
|
5.95374e-06
|
|
|
PPARA
|
[NCBI]
|
5.42327e-06
|
|
|
HLA-A
|
[NCBI]
|
5.34515e-06
|
|
|
AD
|
[NCBI]
|
5.24574e-06
|
|
|
ABCB11
|
[NCBI]
|
4.59059e-06
|
|
|
APOE
|
[NCBI]
|
4.51915e-06
|
|
|
ABCC2
|
[NCBI]
|
4.51137e-06
|
|
|
ASS
|
[NCBI]
|
4.47242e-06
|
|
|
PKD1
|
[NCBI]
|
4.4339e-06
|
|
|
LBP
|
[NCBI]
|
4.4339e-06
|
|
|
homocystinuria
|
[NCBI]
|
4.39581e-06
|
|
|
PC
|
[NCBI]
|
4.07083e-06
|
|
|
UCP2
|
[NCBI]
|
4.0027e-06
|
|
|
PG
|
[NCBI]
|
3.59168e-06
|
|
|
LPL
|
[NCBI]
|
3.44793e-06
|
|
|
ABCB1
|
[NCBI]
|
3.28181e-06
|
|
|
STAT1
|
[NCBI]
|
3.20259e-06
|
|
|
VDR
|
[NCBI]
|
3.12503e-06
|
|
|
TG
|
[NCBI]
|
2.91931e-06
|
|
|
G6PD
|
[NCBI]
|
2.74519e-06
|
|
|
CD
|
[NCBI]
|
2.66649e-06
|
|
|
SPP1
|
[NCBI]
|
1.9612e-06
|
|
|
SHBG
|
[NCBI]
|
1.66588e-06
|
|
|
ABP1
|
[NCBI]
|
1.59464e-06
|
|
|
F3
|
[NCBI]
|
1.24716e-06
|
|
|
TLR2
|
[NCBI]
|
1.23663e-06
|
|
|
TYMS
|
[NCBI]
|
1.16847e-06
|
|
|
APOB
|
[NCBI]
|
1.08728e-06
|
|
|
RA
|
[NCBI]
|
9.70728e-07
|
|
|
CEACAM5
|
[NCBI]
|
9.6726e-07
|
|
|
TF
|
[NCBI]
|
7.48665e-07
|
|
|
MG
|
[NCBI]
|
6.7526e-07
|
|
|
GPI
|
[NCBI]
|
5.20712e-07
|
|
|
STAT3
|
[NCBI]
|
4.10411e-07
|
|
|
TTR
|
[NCBI]
|
3.91188e-07
|
|
|
GAPDH
|
[NCBI]
|
2.8849e-07
|
|
|
CF
|
[NCBI]
|
1.22984e-07
|
|
|
TFPI
|
[NCBI]
|
8.77021e-08
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
5.02456e-08
|
|
|
ACP5
|
[NCBI]
|
2.25348e-08
|
|